HeyJaredGenetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News (GEN) is a specialized trade and news outlet focused on advances across biotechnology, genetic engineering, and the life sciences.
- Indexed articles, last 90 days
- 15
- Latest publication
- Aug 3, 2026
- Audience
- Top 5M sites
- Earliest in this view
- Jul 5, 2026
Latest articles
Combined Phage Therapy and FMT Reduces Recurrent UTIs and Antibiotic Use in First Human Case Series (opens the original)
Read excerpt
The first use of combined phage therapy and fecal microbiota transplantation for recurrent urinary tract infections reduced antibiotic use and improved quality of life in three women, supporting future clinical trials. The post Combined Phage Therapy and FMT Reduces Recurrent UTIs and Antibiotic Use in First Human Case Series appeared first on GEN - Genetic Engineering and Biotechnology News.
Evolutionarily Diverse Organisms Switch Genes on Simply and Switch Them off Dynamically (opens the original)
Read excerpt
A new study has found that the signals cells use to switch genes on have remained almost unchanged across two billion years of evolution, but the ones used to switch genes off vary dramatically from one branch of life to another. The post Evolutionarily Diverse Organisms Switch Genes on Simply and Switch Them off Dynamically appeared first on GEN - Genetic Engineering and Biotechnology News.
Receptor.AI and Sethera Plan to Create Closed-Loop Discovery and Optimization Workflow for Difficult Therapeutic Targets (opens the original)
Read excerpt
The collaboration is specifically focused on applying Receptor.AI's computational platform to Sethera's proprietary polymacrocyclic peptide chemistry, encoded screening data, and resulting therapeutic candidates. Each company will retain its background platform technologies. The post Receptor.AI and Sethera Plan to Create Closed-Loop Discovery and Optimization Workflow for Difficult Therapeutic Targets appeared first on <a href="https://www.genengne
StockWatch: Capricor Plunges as FDA Panel, Staff Question Effectiveness of Lead Candidate Deramiocel (opens the original)
Read excerpt
After seeing its lead candidate rejected by the FDA last year, Capricor Therapeutics is hoping for a better outcome for its resubmitted BLA for its lead pipeline candidate Deramiocel. The post StockWatch: Capricor Plunges as FDA Panel, Staff Question Effectiveness of Lead Candidate Deramiocel appeared first on GEN - Genetic Engineering and Biotechnology News.
Ketamine Triggers Sex-Specific Brain Recovery Responses (opens the original)
Read excerpt
A study in mice has shown how shown that microglia immune cells in the brain play a critical role in how the brain recovers from ketamine anesthesia, and indicates that there are differences between female and male brains. The post Ketamine Triggers Sex-Specific Brain Recovery Responses appeared first on GEN - Genetic Engineering and Biotechnology News.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.